chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant patient received both doses of the Moderna Covid 19 vaccine; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant patient received both doses of the Moderna Covid 19 vaccine) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1st 037K20A / 2nd 042L20A) for COVID-19 vaccination.  No Medical History information was reported.  On 24-Dec-2020, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 31-Oct-2020 and the estimated date of delivery was 07-Aug-2021. On 24-Dec-2020, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant patient received both doses of the Moderna Covid 19 vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the seventh week of the pregnancy. On 22-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnant patient received both doses of the Moderna Covid 19 vaccine) had resolved.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.  No concomitant medications reported by investigator No treatment medications provided by the reporter.  The patient's positive pregnancy test was on 26-Nov-2020 and estimated date of conception was 11-12 Nov-2020.  Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: shortness of breath; chest tightness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (chest tightness) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (chest tightness). At the time of the report, DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (chest tightness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: Pain of arthritis severe left arm; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Pain of arthritis severe left arm) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037T2KUA) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (Pain of arthritis severe left arm). The patient was treated with PARACETAMOL (TYLENOL) for Arthritis, at a dose of UNK, bid. At the time of the report, ARTHRITIS (Pain of arthritis severe left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Outcome of event updated as resolved.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: the place becomes more red; very itchy; site was red and itchy; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (site was red and itchy), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (the place becomes more red) and VACCINATION SITE PRURITUS (very itchy) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (site was red and itchy) and VACCINATION SITE PRURITUS (itchy). On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (the place becomes more red) and VACCINATION SITE PRURITUS (very itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (site was red and itchy), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (the place becomes more red) and VACCINATION SITE PRURITUS (very itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Vaccination site swelling, Vertigo
Clinical narrative: dizziness; vertigo; weakness; vaccination site swell; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VERTIGO (vertigo), ASTHENIA (weakness) and VACCINATION SITE SWELLING (vaccination site swell) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced DIZZINESS (dizziness), VERTIGO (vertigo), ASTHENIA (weakness) and VACCINATION SITE SWELLING (vaccination site swell). At the time of the report, DIZZINESS (dizziness), VERTIGO (vertigo), ASTHENIA (weakness) and VACCINATION SITE SWELLING (vaccination site swell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Polyuria
Clinical narrative: urinating profusely; headache; nausea; fatigue; A spontaneous report was received from a consumer concerning a 76-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events headache, nausea, fatigue, and urinating profusely.  The patient's medical history was not provided. Other relevant concomitant medicines include an extensive amount of medications which were not documented and the patient ha a long medical history for her age which was not documented as well.  On 20 Jan 2021, prior to the onset of the events the patient received the first of two planned doses of mRNA-1273 (lot/batch: 0320L2A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 20 Jan 2021, the patient experienced the events of headache, nausea, fatigue,  and urinating profusely after receiving the vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, headache, nausea, fatigue, and urinating profusely was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus, Vaccination site erythema
Clinical narrative: Arm sore; Red down the arm below elbow; Itching; Red spot; Arm swollen to elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore), ERYTHEMA (Red down the arm below elbow), PRURITUS (Itching), PERIPHERAL SWELLING (Arm swollen to elbow) and VACCINATION SITE ERYTHEMA (Red spot) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm swollen to elbow). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm sore), ERYTHEMA (Red down the arm below elbow), PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (Red spot). At the time of the report, PAIN IN EXTREMITY (Arm sore), ERYTHEMA (Red down the arm below elbow), PRURITUS (Itching), PERIPHERAL SWELLING (Arm swollen to elbow) and VACCINATION SITE ERYTHEMA (Red spot) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Left part of her face started to feel "numbish"; Red, hot, and itchy at the injection site; Red, hot, and itchy at the injection site; Red, hot, and itchy at the injection site; Tiredness; Swelling/Arm became swollen; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness), VACCINATION SITE SWELLING (Swelling/Arm became swollen), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Red, hot, and itchy at the injection site) and VACCINATION SITE WARMTH (Red, hot, and itchy at the injection site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced FATIGUE (Tiredness), VACCINATION SITE SWELLING (Swelling/Arm became swollen) and VACCINATION SITE PAIN (Pain at the injection site). On 07-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red, hot, and itchy at the injection site), VACCINATION SITE WARMTH (Red, hot, and itchy at the injection site) and VACCINATION SITE PRURITUS (Red, hot, and itchy at the injection site). On 15-Jan-2021, the patient experienced HYPOAESTHESIA (Left part of her face started to feel "numbish"). At the time of the report, FATIGUE (Tiredness), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Red, hot, and itchy at the injection site), VACCINATION SITE WARMTH (Red, hot, and itchy at the injection site) and VACCINATION SITE PRURITUS (Red, hot, and itchy at the injection site) outcome was unknown, VACCINATION SITE SWELLING (Swelling/Arm became swollen) had resolved and HYPOAESTHESIA (Left part of her face started to feel "numbish") was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medication included antibiotics for 5 days.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Left part of her face started to feel "numbish"; Red, hot, and itchy at the injection site; Red, hot, and itchy at the injection site; Red, hot, and itchy at the injection site; Tiredness; Swelling/Arm became swollen; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness), VACCINATION SITE SWELLING (Swelling/Arm became swollen), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Red, hot, and itchy at the injection site) and VACCINATION SITE WARMTH (Red, hot, and itchy at the injection site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced FATIGUE (Tiredness), VACCINATION SITE SWELLING (Swelling/Arm became swollen) and VACCINATION SITE PAIN (Pain at the injection site). On 07-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red, hot, and itchy at the injection site), VACCINATION SITE WARMTH (Red, hot, and itchy at the injection site) and VACCINATION SITE PRURITUS (Red, hot, and itchy at the injection site). On 15-Jan-2021, the patient experienced HYPOAESTHESIA (Left part of her face started to feel "numbish"). At the time of the report, FATIGUE (Tiredness), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Red, hot, and itchy at the injection site), VACCINATION SITE WARMTH (Red, hot, and itchy at the injection site) and VACCINATION SITE PRURITUS (Red, hot, and itchy at the injection site) outcome was unknown, VACCINATION SITE SWELLING (Swelling/Arm became swollen) had resolved and HYPOAESTHESIA (Left part of her face started to feel "numbish") was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medication included antibiotics for 5 days.
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Neuralgia, Vaccination site lymphadenopathy, Vaccination site pain
Clinical narrative: Sore arm; really bad nerve pain in the same arm where she got the shot.; In the same arm, in the armpit, she has an area that is really swollen and really tender.; In the same arm, in the armpit, she has an area that is really swollen and really tender.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), NEURALGIA (really bad nerve pain in the same arm where she got the shot.), VACCINATION SITE LYMPHADENOPATHY (In the same arm, in the armpit, she has an area that is really swollen and really tender.) and LYMPH NODE PAIN (In the same arm, in the armpit, she has an area that is really swollen and really tender.) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm), NEURALGIA (really bad nerve pain in the same arm where she got the shot.), VACCINATION SITE LYMPHADENOPATHY (In the same arm, in the armpit, she has an area that is really swollen and really tender.) and LYMPH NODE PAIN (In the same arm, in the armpit, she has an area that is really swollen and really tender.). At the time of the report, VACCINATION SITE PAIN (Sore arm), NEURALGIA (really bad nerve pain in the same arm where she got the shot.), VACCINATION SITE LYMPHADENOPATHY (In the same arm, in the armpit, she has an area that is really swollen and really tender.) and LYMPH NODE PAIN (In the same arm, in the armpit, she has an area that is really swollen and really tender.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Fatigue, Hypoaesthesia oral, Lethargy
Clinical narrative: felt weird (lips numb); Taste of metal; Very tired; Lethargic; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (felt weird (lips numb)), DYSGEUSIA (Taste of metal), FATIGUE (Very tired) and LETHARGY (Lethargic) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONEX) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (felt weird (lips numb)), DYSGEUSIA (Taste of metal), FATIGUE (Very tired) and LETHARGY (Lethargic). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Jan-2021, HYPOAESTHESIA ORAL (felt weird (lips numb)) and DYSGEUSIA (Taste of metal) had resolved. On 21-Jan-2021, FATIGUE (Very tired) and LETHARGY (Lethargic) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: Adverse events, treatment medication, concomitant medication updated.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Injection site erythema, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: low energy; injection site swelling; injection site hot to the touch; arm sore; injection site broken out; injection site red; felt bad; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (low energy), PAIN IN EXTREMITY (arm sore), INJECTION SITE RASH (injection site broken out), INJECTION SITE ERYTHEMA (injection site red) and INJECTION SITE SWELLING (injection site swelling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced MALAISE (felt bad). On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore), INJECTION SITE RASH (injection site broken out), INJECTION SITE ERYTHEMA (injection site red) and INJECTION SITE WARMTH (injection site hot to the touch). On an unknown date, the patient experienced ASTHENIA (low energy) and INJECTION SITE SWELLING (injection site swelling). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, ASTHENIA (low energy), PAIN IN EXTREMITY (arm sore), INJECTION SITE RASH (injection site broken out), INJECTION SITE ERYTHEMA (injection site red), INJECTION SITE SWELLING (injection site swelling), INJECTION SITE WARMTH (injection site hot to the touch) and MALAISE (felt bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information also included ice application.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain in extremity
Clinical narrative: low energy; injection site swelling; injection site hot to the touch; arm sore; injection site broken out; injection site red; felt bad; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (low energy), PAIN IN EXTREMITY (arm sore), INJECTION SITE RASH (injection site broken out), INJECTION SITE ERYTHEMA (injection site red) and INJECTION SITE SWELLING (injection site swelling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced MALAISE (felt bad). On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore), INJECTION SITE RASH (injection site broken out), INJECTION SITE ERYTHEMA (injection site red) and INJECTION SITE WARMTH (injection site hot to the touch). On an unknown date, the patient experienced ASTHENIA (low energy) and INJECTION SITE SWELLING (injection site swelling). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, ASTHENIA (low energy), PAIN IN EXTREMITY (arm sore), INJECTION SITE RASH (injection site broken out), INJECTION SITE ERYTHEMA (injection site red), INJECTION SITE SWELLING (injection site swelling), INJECTION SITE WARMTH (injection site hot to the touch) and MALAISE (felt bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information also included ice application.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Upper-airway cough syndrome
Clinical narrative: postnasal drip; think this might be COVID symptoms; Chills; This spontaneous case was reported by a consumer and describes the occurrence of UPPER-AIRWAY COUGH SYNDROME (postnasal drip), COVID-19 (think this might be COVID symptoms) and CHILLS (Chills) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011320A) for COVID-19 vaccination.     Concomitant products included VITAMIN B NOS for an unknown indication.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced UPPER-AIRWAY COUGH SYNDROME (postnasal drip), COVID-19 (think this might be COVID symptoms) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) on 18-Jan-2021 at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) on 19-Jan-2021 at an unspecified dose and frequency. At the time of the report, UPPER-AIRWAY COUGH SYNDROME (postnasal drip), COVID-19 (think this might be COVID symptoms) and CHILLS (Chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included antidepressants.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Papule, Rash pruritic, Urticaria
Clinical narrative: Bump on stomach; 18 hives all over his body and face; which was itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAPULE (Bump on stomach), URTICARIA (18 hives all over his body and face) and RASH PRURITIC (which was itchy) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20H) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAPULE (Bump on stomach) and RASH PRURITIC (which was itchy). 19-Jan-2021, the patient experienced URTICARIA (18 hives all over his body and face). At the time of the report, PAPULE (Bump on stomach), URTICARIA (18 hives all over his body and face) and RASH PRURITIC (which was itchy) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided. Treatment information not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Balance disorder, Erythema, Hypersomnia, Induration
Clinical narrative: Nauseated; Affecting my balance; Legs crampy; Sore arm; Hard arm; Swelled arm; Red arm; I Sleep for a couple of more hours and that was unusual; Sick of my stomach; Arm started itching; Low grade fever; Didn't feel really good; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm started itching), PYREXIA (Low grade fever), MALAISE (Didn't feel really good), NAUSEA (Nauseated) and BALANCE DISORDER (Affecting my balance) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and High cholesterol. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR OD) for High cholesterol, CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Arm started itching), PYREXIA (Low grade fever) and MALAISE (Didn't feel really good). On 19-Jan-2021, the patient experienced NAUSEA (Nauseated), BALANCE DISORDER (Affecting my balance), MUSCLE SPASMS (Legs crampy), PAIN IN EXTREMITY (Sore arm), INDURATION (Hard arm), PERIPHERAL SWELLING (Swelled arm), ERYTHEMA (Red arm), HYPERSOMNIA (I Sleep for a couple of more hours and that was unusual) and ABDOMINAL DISCOMFORT (Sick of my stomach). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRURITUS (Arm started itching), PYREXIA (Low grade fever), MALAISE (Didn't feel really good), NAUSEA (Nauseated), BALANCE DISORDER (Affecting my balance), MUSCLE SPASMS (Legs crampy), PAIN IN EXTREMITY (Sore arm), INDURATION (Hard arm), PERIPHERAL SWELLING (Swelled arm), ERYTHEMA (Red arm), HYPERSOMNIA (I Sleep for a couple of more hours and that was unusual) and ABDOMINAL DISCOMFORT (Sick of my stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details :Stomach sick medicine.  Concomitant medications also included blood pressure medication and blood thinner medicine.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Muscle spasms, Nausea, Pain in extremity, Peripheral swelling
Clinical narrative: Nauseated; Affecting my balance; Legs crampy; Sore arm; Hard arm; Swelled arm; Red arm; I Sleep for a couple of more hours and that was unusual; Sick of my stomach; Arm started itching; Low grade fever; Didn't feel really good; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm started itching), PYREXIA (Low grade fever), MALAISE (Didn't feel really good), NAUSEA (Nauseated) and BALANCE DISORDER (Affecting my balance) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and High cholesterol. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR OD) for High cholesterol, CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Arm started itching), PYREXIA (Low grade fever) and MALAISE (Didn't feel really good). On 19-Jan-2021, the patient experienced NAUSEA (Nauseated), BALANCE DISORDER (Affecting my balance), MUSCLE SPASMS (Legs crampy), PAIN IN EXTREMITY (Sore arm), INDURATION (Hard arm), PERIPHERAL SWELLING (Swelled arm), ERYTHEMA (Red arm), HYPERSOMNIA (I Sleep for a couple of more hours and that was unusual) and ABDOMINAL DISCOMFORT (Sick of my stomach). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRURITUS (Arm started itching), PYREXIA (Low grade fever), MALAISE (Didn't feel really good), NAUSEA (Nauseated), BALANCE DISORDER (Affecting my balance), MUSCLE SPASMS (Legs crampy), PAIN IN EXTREMITY (Sore arm), INDURATION (Hard arm), PERIPHERAL SWELLING (Swelled arm), ERYTHEMA (Red arm), HYPERSOMNIA (I Sleep for a couple of more hours and that was unusual) and ABDOMINAL DISCOMFORT (Sick of my stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details :Stomach sick medicine.  Concomitant medications also included blood pressure medication and blood thinner medicine.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: Nauseated; Affecting my balance; Legs crampy; Sore arm; Hard arm; Swelled arm; Red arm; I Sleep for a couple of more hours and that was unusual; Sick of my stomach; Arm started itching; Low grade fever; Didn't feel really good; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm started itching), PYREXIA (Low grade fever), MALAISE (Didn't feel really good), NAUSEA (Nauseated) and BALANCE DISORDER (Affecting my balance) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and High cholesterol. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR OD) for High cholesterol, CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Arm started itching), PYREXIA (Low grade fever) and MALAISE (Didn't feel really good). On 19-Jan-2021, the patient experienced NAUSEA (Nauseated), BALANCE DISORDER (Affecting my balance), MUSCLE SPASMS (Legs crampy), PAIN IN EXTREMITY (Sore arm), INDURATION (Hard arm), PERIPHERAL SWELLING (Swelled arm), ERYTHEMA (Red arm), HYPERSOMNIA (I Sleep for a couple of more hours and that was unusual) and ABDOMINAL DISCOMFORT (Sick of my stomach). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRURITUS (Arm started itching), PYREXIA (Low grade fever), MALAISE (Didn't feel really good), NAUSEA (Nauseated), BALANCE DISORDER (Affecting my balance), MUSCLE SPASMS (Legs crampy), PAIN IN EXTREMITY (Sore arm), INDURATION (Hard arm), PERIPHERAL SWELLING (Swelled arm), ERYTHEMA (Red arm), HYPERSOMNIA (I Sleep for a couple of more hours and that was unusual) and ABDOMINAL DISCOMFORT (Sick of my stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details :Stomach sick medicine.  Concomitant medications also included blood pressure medication and blood thinner medicine.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: injection site was raised; iinjection site was red; injection site was warm; headache; has been a little tired; Had a little soreness went away in 1 day; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Had a little soreness went away in 1 day), HEADACHE (headache), FATIGUE (has been a little tired), INJECTION SITE SWELLING (injection site was raised) and INJECTION SITE ERYTHEMA (iinjection site was red) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PROBIOTICS NOS for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced INJECTION SITE PAIN (Had a little soreness went away in 1 day). On 12-Jan-2021, the patient experienced HEADACHE (headache) and FATIGUE (has been a little tired). On 18-Jan-2021, the patient experienced INJECTION SITE SWELLING (injection site was raised), INJECTION SITE ERYTHEMA (iinjection site was red) and INJECTION SITE WARMTH (injection site was warm). The patient was treated with PARACETAMOL (TYLENOL) for Inflammation, at an unspecified dose and frequency. On 12-Jan-2021, INJECTION SITE PAIN (Had a little soreness went away in 1 day) had resolved. At the time of the report, HEADACHE (headache), FATIGUE (has been a little tired), INJECTION SITE SWELLING (injection site was raised), INJECTION SITE ERYTHEMA (iinjection site was red) and INJECTION SITE WARMTH (injection site was warm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth
Clinical narrative: injection site was raised; iinjection site was red; injection site was warm; headache; has been a little tired; Had a little soreness went away in 1 day; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Had a little soreness went away in 1 day), HEADACHE (headache), FATIGUE (has been a little tired), INJECTION SITE SWELLING (injection site was raised) and INJECTION SITE ERYTHEMA (iinjection site was red) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PROBIOTICS NOS for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced INJECTION SITE PAIN (Had a little soreness went away in 1 day). On 12-Jan-2021, the patient experienced HEADACHE (headache) and FATIGUE (has been a little tired). On 18-Jan-2021, the patient experienced INJECTION SITE SWELLING (injection site was raised), INJECTION SITE ERYTHEMA (iinjection site was red) and INJECTION SITE WARMTH (injection site was warm). The patient was treated with PARACETAMOL (TYLENOL) for Inflammation, at an unspecified dose and frequency. On 12-Jan-2021, INJECTION SITE PAIN (Had a little soreness went away in 1 day) had resolved. At the time of the report, HEADACHE (headache), FATIGUE (has been a little tired), INJECTION SITE SWELLING (injection site was raised), INJECTION SITE ERYTHEMA (iinjection site was red) and INJECTION SITE WARMTH (injection site was warm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: small rash that is red where got the vaccine; small rash that is red where got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (small rash that is red where got the vaccine) and INJECTION SITE ERYTHEMA (small rash that is red where got the vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METOPROLOL and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced INJECTION SITE RASH (small rash that is red where got the vaccine) and INJECTION SITE ERYTHEMA (small rash that is red where got the vaccine). At the time of the report, INJECTION SITE RASH (small rash that is red where got the vaccine) and INJECTION SITE ERYTHEMA (small rash that is red where got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included cold rag.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: 5-6 inches rash; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of   in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Vaccination site pain
Clinical narrative: Sweling lymph node under left arm pit; swollen lymph node in left side of her neck; Arm soreness; Fatigue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Arm soreness), LYMPHADENOPATHY (Sweling lymph node under left arm pit), FATIGUE (Fatigue) and LYMPHADENOPATHY (swollen lymph node in left side of her neck) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history.). Concomitant products included LEVOTHYROXINE and AZILSARTAN for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness) and FATIGUE (Fatigue). On 19-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LYMPHADENOPATHY (Sweling lymph node under left arm pit) and LYMPHADENOPATHY (swollen lymph node in left side of her neck). At the time of the report, VACCINATION SITE PAIN (Arm soreness) and FATIGUE (Fatigue) outcome was unknown and LYMPHADENOPATHY (Sweling lymph node under left arm pit) and LYMPHADENOPATHY (swollen lymph node in left side of her neck) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Fever; Chills; Swelling; Fatigue; Itching left arm; REDNESS; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching left arm), VACCINATION SITE ERYTHEMA (REDNESS), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching left arm), VACCINATION SITE ERYTHEMA (REDNESS) and FATIGUE (Fatigue). On 12-Jan-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and VACCINATION SITE SWELLING (Swelling). On 12-Jan-2021, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. On 13-Jan-2021, FATIGUE (Fatigue) outcome was unknown. At the time of the report, VACCINATION SITE PRURITUS (Itching left arm), VACCINATION SITE ERYTHEMA (REDNESS) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Fever; Chills; Swelling; Fatigue; Itching left arm; REDNESS; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching left arm), VACCINATION SITE ERYTHEMA (REDNESS), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching left arm), VACCINATION SITE ERYTHEMA (REDNESS) and FATIGUE (Fatigue). On 12-Jan-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and VACCINATION SITE SWELLING (Swelling). On 12-Jan-2021, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. On 13-Jan-2021, FATIGUE (Fatigue) outcome was unknown. At the time of the report, VACCINATION SITE PRURITUS (Itching left arm), VACCINATION SITE ERYTHEMA (REDNESS) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: red, itchy injection site on upper arm; red, itchy injection site on upper arm; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red, itchy injection site on upper arm), VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (red, itchy injection site on upper arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported historical condition). Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (red, itchy injection site on upper arm) and VACCINATION SITE ERYTHEMA (red, itchy injection site on upper arm). At the time of the report, VACCINATION SITE PRURITUS (red, itchy injection site on upper arm), VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (red, itchy injection site on upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Discomfort, Disorientation, Pain in extremity, Speech disorder
Clinical narrative: Arm is very painful; Arm is swollen; The knot is about the size of a peach; The knot  is very warm; has been vomiting non stop; Was very disoriented; Could not make out a complete sentence; Had been feeling pretty sick; very uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had been feeling pretty sick), DISCOMFORT (very uncomfortable), VOMITING (has been vomiting non stop), DISORIENTATION (Was very disoriented) and SPEECH DISORDER (Could not make out a complete sentence) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Restless legs syndrome (Reported by patient that she takes medication for restless legs syndrome) and Insulin-dependent diabetes mellitus (Reported that patient is an insulin dependent diabetic and has an insulin pump). Concomitant products included AMITRIPTYLINE for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION COMPLICATION (Had been feeling pretty sick) and DISCOMFORT (very uncomfortable). On 16-Jan-2021, the patient experienced VOMITING (has been vomiting non stop), DISORIENTATION (Was very disoriented) and SPEECH DISORDER (Could not make out a complete sentence). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is very painful), VACCINATION SITE SWELLING (Arm is swollen), VACCINATION SITE INDURATION (The knot is about the size of a peach) and VACCINATION SITE WARMTH (The knot  is very warm). On 16-Jan-2021, VACCINATION COMPLICATION (Had been feeling pretty sick) and DISCOMFORT (very uncomfortable) had resolved. On 18-Jan-2021, VOMITING (has been vomiting non stop), DISORIENTATION (Was very disoriented) and SPEECH DISORDER (Could not make out a complete sentence) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm is very painful), VACCINATION SITE SWELLING (Arm is swollen), VACCINATION SITE INDURATION (The knot is about the size of a peach) and VACCINATION SITE WARMTH (The knot  is very warm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Blood glucose: 146 or 156 mg/dl (High) blood sugar was 146 or 156 in the morning( the patient couldn't remember) ) and started dropping .. On 19-Jan-2021, Blood glucose: 88 mg/dl morning -88mg/dl.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment included acetaminophen.